Katia Scotlandi

Publications prior to 2004

1. De Giovanni C, Lollini PL, Nicoletti G, Del Re B, Scotlandi K, Prodi G, Nanni P.

   Growth and metastasis in allogeneic hosts. Lack of H-2 negative or somatic hybrid variant selection. Expl. Clin. Immunogenet., 4:153-162, 1987.

2. Lollini PL, De Giovanni C, Del Re B, Nicoletti G, Prodi G, Scotlandi K, Nanni P.

   Interferon-mediated modulation of metastasis and MHC antigens. Adv Exp Med Biol. 1988;233:129-39. I.F. (2016/2017): 1.881

3. De Giovanni C, Lollini PL, Del Re B, Nicoletti G, Prodi G, Scotlandi K, Nanni P.

   Heterogeneity and clonal interactions in the TS/A murine mammary adenocarcinoma. Adv Exp Med Biol. 1988;233:5-14. I.F. (2016/2017): 1.881

4. Nanni P, De Giovanni C, Nicoletti G, Del Re B, Scotlandi K, Lollini PL.

   Human rhabdomyosarcoma cells in nude mice as a model for metastasis and differentiation.

   Invasion Metastasis, 9: 231-241, 1989.

5. C De Giovanni, G Nicoletti, B Del Re, K Scotlandi, G Prodi, PL Lollini, P Nanni.

   Tumorigenic and metastatic ability of SV40-transformed BALB/c cell lines and MHC antigen expression. J. Immunogenetics, 16: 45-51, 1989.

6. PL Lollini, C De Giovanni, B Del Re, L Landuzzi, G Nicoletti, G Prodi, K Scotlandi, P Nanni.

   Myogenic differentiation of human rhabdomyosarcoma cells induced in vitro by antineoplastic drugs. Cancer Res., 49: 3631-3636, 1989. I.F. (2016/2017): 9.122

7. G Nicoletti, C De Giovanni, PL Lollini, GP Bagnara, K Scotlandi, L Landuzzi, B Del Re, G Zauli, G Prodi, P Nanni.

   In vivo and in vitro production of haemopoietic colony-stimulating activity by murine cell lines of different origin: a frequent finding. Eur. J. Cancer Clin Oncol., 25: 1281-1286, 1989.

8. PL Lollini, C De Giovanni, G Nicoletti, K Scotlandi, L Landuzzi, P Nanni.

   Modulation by IFN-gamma of the metastatic ability of murine, human, and H-2-transfected tumor cells. Tumori, 75: 383-388, 1989. I.F. (2016/2017): 1.233

9. C De Giovanni, P Nanni, G Nicoletti, C Ceccarelli, K Scotlandi, L Landuzzi, PL Lollini.

   Metastatic ability and differentiative properties of a new cell line of human embryonal rhabdomyosarcoma (CCA). Anticancer Res., 9: 1943-1950,1989. I.F. (2016/2017): 1.937

10. PL Lollini, C De Giovanni, G Nicoletti, A Bontadini, PL Tazzari, L Landuzzi, K Scotlandi, P Nanni.

    Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma. Clin. Expl. Metastasis, 8: 215-224, 1990. I.F. (2016/2017): 3.144

11. PL Lollini, C De Giovanni, L Landuzzi, G Nicoletti, K Scotlandi, P Nanni.

    Reduced metastatic ability of in vitro differentiated human rhabdomyosarcoma cells. Invasion Metastasis, 11: 116-124, 1991.

12. P Nanni, G Azzarello, L. Tessarollo, C De Giovanni, PL Lollini, G Nicoletti, K Scotlandi, L Landuzzi, M Panozzo, E D'Andrea, S Schiaffino, L Chieco-Bianchi.

    In vitro differentiation of rhabdomyosarcomas induced by nickel or by Moloney Murine Sarcoma Virus. British J. Cancer, 63: 736-742, 1991. I.F. (2016/2017): 6.176

13. C De Giovanni, G Palmieri, G Nicoletti, L Landuzzi, K Scotlandi, A Bontadini, PL Tazzari, M Sensi, A Santoni, P Nanni, PL Lollini.

    Immunological and non-immunological influence of H-2Kb gene transfection on the metastatic ability of B16 melanoma cells. Int. J. Cancer, 48: 270-276, 1991. I.F. (2016/2017): 6.513

14. M Serra, MC Morini, K Scotlandi, LW Fisher, N Zini, MP Colombo, M Campanacci, NM Maraldi, S Olivari, N Baldini.

    Evaluation of Osteonectin as a diagnostic marker of osteogenic bone tumors. Human Pathology, 23:1326-1331, 1992. I.F. (2016/2017): 3.014

15. K Scotlandi, M Serra, L Landuzzi, N Baldini.

    SARG: a new human osteosarcoma cell line. Expression of bone markers and of major histocompatibility antigens. Ann Oncology, 3 (suppl.2): 29-31,1992. I.F. (2016/2017): 11.855

16. K Scotlandi, N Baldini, M Campanacci, PL Lollini, P Picci, M Serra.

    Induction of HLA class II antigens in osteosarcoma cells by Interferons and Tumor Necrosis Factor Alpha. Anticancer Research, 12: 767-772, 1992. I.F. (2016/2017): 1.937

17. N Baldini, K Scotlandi, M Serra, K Kusuzaki, T Shikita, MC Manara, D Maurici, M Campanacci.

    Adriamycin Binding Assay: a valuable chemosensitivity test in human osteosarcoma. J. Cancer Res Clinical Oncol., 119: 121-126, 1992. I.F. (2016/2017): 3.503

18. M Grano, S Colucci, A Portoghese, G Zambonin, R Barattolo, M Serra, K Scotlandi, A Teti, A Zambonin Zallone.

    Functional and biochemical characterization of osteoclast-like cells derived from giant cell tumors of bone. Boll. Soc. It. Biol. Sper., LXVIII: 249-253, 1992.

19. M Giovannini, L Selleri, JA Biegel, K Scotlandi,BS Emanuel, GA Evans.

    Interphase cytogenetics for the detection of the t(11;22)(q24;ql2) in small round cell tumors. J. Clin Invest., 90: 1911-1918, 1992. I.F. (2016/2017): 12.784

20. M Grano, S Colucci, P Zigrino, M Serra, K Scotlandi, A Teti, A Zambonin Zallone.

    Integrin expression and adhesion property of osteoclast-like cells from giant cell tumours of bone. Boll. Soc. It. Biol. Sper., LXVIII: 255-258, 1992.

21. C De Giovanni, PL Lollini, R Dolcetti, L Landuzzi, G Nicoletti, E D'Andrea, K Scotlandi, P Nanni.

    Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells. British J. Cancer, 67: 674-679, 1993. I.F. (2016/2017): 6.176

22. M Serra, K Scotlandi, MC Manara, D Maurici, PL Lollini, C De Giovanni, G Toffoli, N Baldini.

    Establishment and characterization of multidrug-resistant human osteosarcoma cell lines. Anticancer Research, 13: 323-329, 1993. I.F. (2016/2017): 1.937

23. K Scotlandi, M Serra, MC Manara, P Nanni, G Nicoletti, L Landuzzi, D Maurici, N Baldini.

    Human osteosarcoma cells, tumorigenic in nude mice, express ß1 integrins and low levels of alkaline phosphatase activity. Int. J. Oncology, 3:963-969, 1993. I.F. (2016/2017): 3.079

24. K Scotlandi, M Serra, MC Manara, PL Lollini, D Maurici, D Del Bufalo, N Baldini.

    Pre-treatment of human osteosarcoma cells with N-Methylformamide enhances p-glycoprotein expression and resistance to doxorubicin. Int. J. Cancer, 58:95-101, 1994. I.F. (2016/2017): 6.513

25. M Grano, S Colucci, M De Bellis, P Zigrino, L Argentino, G Zambonin, M Serra, K Scotlandi, A Teti, A Zambonin Zallone.

    New model for bone resorption study in vitro: human osteoclast-like cells from giant cell tumors of bone. J. of Bone and Mineral Research, 9:1013-1020, 1994. I.F. (2016/2017): 6.284

26. K Scotlandi, M Serra, MC Manara, D Maurici, S Benini, G Nini, M Campanacci, N Baldini.

    Clinical relevance of Ki-67 expression in bone tumors. Cancer, 1995 Feb 1;75(3):806-14. I.F. (2016/2017): 5.997

27. R Ferracini, MF Di Renzo, K Scotlandi, N Baldini, M Olivero, PL Lollini, O Cremona, M Campanacci, PM Comoglio.

    The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene, 10: 739-749, 1995. I.F. (2016/2017): 7.519

28. M De Mattei, F Martini, A Corallini, M Gerosa, K Scotlandi, P Carinci, G Barbanti-Brodano, M. Tognon.

    High incidence of BKV large T antigen coding sequences in normal human tissues and tumors of different histotypes. Int. J. Cancer, 1995 Jun 9; 61(6):756-760. I.F. (2016/2017): 6.513

29. MC Manara, K Scotlandi, M Serra, D Maurici, M Sarti, M Campanacci, N Baldini.

    Absence of stimulatory effect of G-CSF on the growth of human sarcoma cells. Int. J. Oncology, 6:1011-1014, 1995. I.F. (2016/2017): 3.079

30. N Baldini, K Scotlandi, M Serra, T Shikita, N Zini, A Ognibene, S Santi, R Ferracini, NM Maraldi.

    Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar machanisms od doxorubicin distribution. Eur. J. Cell. Biol., 68:226-239, 1995. I.F. (2016/2017): 3.712

31. R Paniccia, T Riccioni, BM Zani, P Zigrino, K Scotlandi, A Teti.

    Calcitonin down-regulates immediate cell signals induced in human osteoclast-like cells by the bone sialoprotein II A fragment, through a post-integrin receptor mechanism. Endocrinology, 1995 Mar;136(3):1177-86. I.F. (2016/2017): 4.286

32. M Serra, K Scotlandi, MC Manara, D Maurici, S Benini, M Sarti, M Campanacci, N Baldini.

    Analysis of P-glycoprotein expression in osteosarcoma. Eur. J. Cancer, 31:1998-2002, 1995. I.F. (2016/2017): 6.029

33. N Baldini, K Scotlandi, G Barbanti-Brodano, MC Manara, D Maurici, G Bacci, F Bertoni, P Picci, S Sottili, M Campanacci, M Serra.

    Expression of P-glycoprotein in high-grade osteosarcoma and clinical outcome. New Engl J Med. 1995 Nov 23;333(21):1380-5. I.F. (2016/2017): 72.406

34. N Zini, K Scotlandi, N Baldini, G Nini, P Sabatelli, NM Maraldi.

    Multidrug-resistance (MDR) phenotype of human osteosarcoma cells evaluated by quantitative morphological and electron microscopy analyses. Biol. Cell., 84:195-204, 1995. I.F. (2016/2017): 2.649

35. NM Maraldi, N Zini, P Sabatelli, A Valmori, K Scotlandi, M Serra, N Baldini.

    Ultrastructural features and P-glycoprotein immunolocalization in Saos-2/DX580 multidrug-resistant human osteosarcoma cells. J. Submicrosc. Cytol. Pathol., 28:93-100, 1996.

36. K Scotlandi, M Serra, MC Manara, S Benini, M Sarti, D Maurici, PL Lollini, P Picci, F Bertoni, N Baldini.

    Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumor. Human Pathol., 27: 408-416, 1996. I.F. (2016/2017): 3.014

37. R Ferracini, M Olivero, MF Di Renzo, M Martano, C De Giovanni, P Nanni, G Basso, K Scotlandi, PL Lollini, PM Comoglio.

    Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcoma. Oncogene, 12: 1697-1705, 1996. I.F. (2016/2017): 7.519

38. M Serra, K Scotlandi, MR Sollazzo, M Sarti, D Maurici, S Benini, P Picci, F Bertoni, N Baldini.

    Value of immunohistochemical detection of noncollagenous proteins of bone for the diagnosis of bone tumors. Int. J. Oncology, 9: 257-261, 1996. I.F. (2016/2017): 3.079

39. M Serra, K Scotlandi, MC Manara, D Maurici, S Benini, M Sarti, G Nini, G Barbanti-Brodano, N Baldini.

    Evaluation of P-glycoprotein expression in soft tissue sarcomas of the extremities. Cytotechnology, 19: 253-256, 1996. I.F. (2016/2017): 1.857

40. K Scotlandi, M Serra, G Nicoletti, M Vaccari, MC Manara, G Nini, L Landuzzi, A Colacci, G Bacci, F Bertoni, P Picci, M Campanacci, N Baldini.

    Multidrug resistance and malignancy in human osteosarcoma. Cancer Res., 56: 2434-2439, 1996. I.F. (2016/2017): 9.122

41. K Scotlandi, S Benini, M Sarti, M Serra, PL Lollini, D Maurici, P Picci, MC Manara, N Baldini.

    Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target. Cancer Research, 56: 4570-4574, 1996. I.F. (2016/2017): 9.122

42. N Zini, A Ognibene, A Bavelloni, S Santi, P Sabatelli, N Baldini, K Scotlandi, M Serra, NM Maraldi.

    Cytoplasmic and nuclear localization sites of phosphatidylinositol 3-kinase in human osteosarcoma sensistive and multidrug-resistant Saos-2 cells. Histochem. Cell Biol, 106: 457-464, 1996. I.F. (2016/2017): 2.553

43. K Scotlandi, N Baldini, M Oliviero, MF Di Renzo, M Martano, M Serra, MC Manara, PM Comoglio, R Ferracini.

    Expression of Met/Hepatocyte Growth Factor receptor gene and malignant behavior of musculoskeletal tumors. Am. J. Pathology, 149: 1209-1219, 1996. I.F. (2016/2017): 4.057

44. S Colucci, M Grano, G Mori, K Scotlandi, M Mastrogiacomo, C Mori, A Zambonin Zallone.

    Retinoic acid induces cell proliferation and modulates gelatinases activity in human osteoclast-like cell lines. Biochem Biophys Res Commun, 227: 47-52, 1996. I.F. (2016/2017): 2.466

45. N Zini, LM Neri, A Ognibene, K Scotlandi, N Baldini, NM Maraldi.

    Increase of nuclear phosphatidylinositol 4,5-biphosphate and phospholipase C 1 is not associated to variations of protein kinase C in multidrug-resistant Saos-2 cells. Microscopy Res. Technique, 36: 172-178, 1997. I.F. (2016/2017): 1.147

46. A Gasbarrini, B Grigolo, M Serra, N Baldini, K Scotlandi, A Gasbarrini, M Bernardi, A Facchini.

    Generation of free radicals during anoxia and reoxygenation in perfused osteoblastlike cells.

    Clinical Orthop. and Related Research, 338, 247:252, 1997. I.F. (2016/2017): 3.897

47. PL Lollini, G Palmieri, C De Giovanni, L Landuzzi, G Nicoletti, I Rossi, C Griffoni, F Frabetti, K Scotlandi, S Benini, N Baldini, A Santoni, P Nanni.

    Expression of interleukin 15 (IL-15) in human rhabdomyosarcoma, osteosarcoma, and Ewing's sarcoma. Int. J. Cancer, 71:732-736, 1997. I.F. (2016/2017): 6.513

48. PL Lollini, L Landuzzi, F Frabetti, I Rossi, G Nicoletti, K Scotlandi, M Serra, N Baldini, C De Giovanni, P. Nanni.

    Expression of functional CD40 on human osteosarcoma and Ewing’s sarcoma cells.

    Clinical Cancer Res., 4: 1843-1849, 1998. I.F. (2016/2017): 9.619

49. K Scotlandi, S Benini, P Nanni, PL Lollini, G Nicoletti, L Landuzzi, M Serra, MC Manara, P Picci, N Baldini.

    Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing’s sarcoma in athymic mice. Cancer Res., 58: 4127-4131, 1998. I.F. (2016/2017): 9.122

50. M Serra, D Maurici, K Scotlandi, G Barbanti-Brodano, MC Manara, S Benini, P Picci, F Bertoni, G Bacci, S Sottili, N Baldini.

    Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcoma.

    Int. J. Oncology, 14: 301-307, 1999. I.F. (2016/2017): 3.079

51. K Scotlandi, MC Manara, M Serra, S Benini, D Maurici, A Caputo, C De Giovanni, PL Lollini, P Nanni, P Picci, M Campanacci, N Baldini.

    The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells. Oncogene, 18: 739-746, 1999. I.F. (2016/2017): 7.519

52. S Benini, N Baldini, MC Manara, T Chano, M Serra, S Rizzi, PL Lollini, P Picci, K Scotlandi.

    Redundancy of autocrine loops in human osteosarcoma cells. Int. J. Cancer, 80: 581-588, 1999. I.F. (2016/2017): 6.513

53. NM Maraldi, N Zini, S Santi, K Scotlandi, M Serra, N Baldini.

    P-glycoprotein subcellular localization and cell morphotype in MDR1 gene-transfected human osteosarcoma cells. Biol Cell, 91: 17-28, 1999. I.F. (2016/2017): 2.649

54. N Baldini, K Scotlandi, M Serra, P Picci, G Bacci, S Sottili, M Campanacci.

    P-glycoprotein expression in osteosarcoma: a basis for risk-adpted adjuivant chemotherapy.

    J. Orthop. Res., 17: 629-632, 1999. I.F. (2016/2017): 2.692

55. JN Shen, K Scotlandi, N Baldini, MC Manara, S Benini, V Cerisano, P Picci, M Serra.

    Prognostic significance of nuclear accumulation of c-myc and mdm2 proteins in synovial sarcoma of the extremities. Oncology, 58: 253-260, 2000. I.F. (2016/2017): 2.262

56. C Ricci, L Landuzzi, I Rossi, C De Giovanni, G Nicoletti, A Astolfi, S Pupa, S Menard, K Scotlandi, P Nanni, PL Lollini.

    Expression of HER/erbB family of receptor tyrosine kinases and induction of differentation by glial growth factor 2 in human rhabdomyosarcoma cells. Int. J. Cancer, 87: 29-36, 2000. I.F. (2016/2017): 6.513

57. MC Manara, N Baldini, M Serra, PL Lollini, C De Giovanni, M Vaccari, A Argnani, S Benini, D Maurici, P Picci, K Scotlandi.

    Reversal of malignant phenotype in human osteosarcoma cells transduced with the alkaline phosphatase gene. Bone, 26: 215-220, 2000. I.F. (2016/2017): 4.14

58. R Ferracini, K Scotlandi, E Cagliero, F Acquarone, M Olivero, J Wunder, N Baldini.

    The expression of Met/hepatocyte growth factor receptor gene in giant cell tumors of bone and other benign musculoskeletal tumors. J. Cell. Physiol., 184: 191-196, 2000. I.F. (2016/2017): 4.08

59. K Scotlandi, N Baldini, V Cerisano, MC Manara, S Benini, M Serra, PL Lollini, P Nanni, G Nicoletti, G Bernard, A Bernard, P Picci.
    CD99 engagement: an effective therapeutic strategy for Ewing tumors. Cancer Res. 2000 Sep 15;60(18):5134-42. I.F. (2016/2017): 9.122
60. K Scotlandi, T Chano, S Benini, M Serra, MC Manara, V Cerisano, P Picci, N Baldini.

    Identification of EWS/FLI-1 transcripts in giant-cell tumor of bone. Int. J. Cancer, 87:328-335, 2000. I.F. (2016/2017): 6.513

61. L Landuzzi, C De Giovanni, G.Nicoletti, I Rossi, C Ricci, A Astolfi, L Scopece, K Scotlandi, M Serra, GP Bagnara, P Nanni, PL Lollini.

    The metastatic ability of Ewing’s sarcoma cells is modulated by stem cell factor and by its receptor c-kit. Am. J. Pathol., 157: 2123-2131, 2000. I.F. (2016/2017): 4.057

62. K Scotlandi, S Benini, MC Manara, M Serra, P Nanni, PL Lollini, G Nicoletti, L Landuzzi, T Chano, P Picci, N Baldini.

    Murine Model for skeletal metastases of Ewing’s sarcoma. J. Orthop. Res., 18: 959-966, 2000. I.F. (2016/2017): 2.692

63. S Benini, MC Manara, N Baldini, V Cerisano, M Serra, M Mercuri, PL Lollini, P Nanni, P Picci, K Scotlandi.

    Inhibition of Insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing’s sarcoma cells. Clin. Cancer Res., 7: 1790-1797, 2001. I.F. (2016/2017): 9.619

64. M Serra, M Tarkkanen, N Baldini, K Scotlandi, M Sarti, D Maurici, MC Manara, S Benini, P Bacchini, S Knuutila, P Picci.

    Simultaneous paired analysis of numerical chromosomal aberrations and DNA content in osteosarcoma. Modern Pathol., 14: 710-716, 2001. I.F. (2016/2017): 5.728

65. AM Porcelli, K Scotlandi, R Strammiello, G Gislimberti, N Baldini, M Rugolo.

    Intracellular pH regulation in U-2 OS human osteosarcoma cells transfected with P-glycoprotein. Biochim. Biophys. Acta. (Molecular Cell Res) 1542 :125-138, 2002. I.F. (2016/2017): 4.521

66. MC Manara, B Perbal, S Benini, R Strammiello, V Cerisano, S Perdichizzi, M Serra, A Astolfi, F Bertoni, J Alami, H Yeger, P Picci, K Scotlandi.

    The expression of ccn3(nov) gene in musculoskeletal tumors. Am J Pathol. 2002 Mar;160(3):849-59. I.F. (2016/2017): 4.057

67. K Scotlandi, C Maini, MC Manara, S Benini, M Serra, V Cerisano, R Strammiello, N Baldini, PL Lollini, P Nanni, G Nicoletti, P Picci.

    Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells. Cancer Gene Ther. 2002 Mar;9(3):296-307. I.F. (2016/2017): 3.652

68. F Martini, L Lazzarin, L Iaccheri, B Vignocchi, G Finocchiaro, I Magnani, M Serra, K Scotlandi, G Barbanti-Brodano, M Tognon.

    Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors. Cancer. 2002 Feb 15;94(4):1037-48. I.F. (2016/2017): 5.997

69. K Scotlandi, S Avnet, S Benini, MC Manara, M Serra, V Cerisano, S Perdichizzi, PL Lollini, C De Giovanni, L Landuzzi, P Picci.

    Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing’s sarcoma cells. Int. J. Cancer. 2002 Sep 1;101(1):11-6. I.F. (2016/2017): 6.513

70. K Scotlandi, S Perdichizzi, MC Manara, M Serra, S Benini, V Cerisano, R Strammiello, M. Mercuri, G Reverter-Branchat, G Faircloth, M D’Incalci, P Picci.

    Effectiveness of Ectinascidin-743 against drug-sensitive and –resistant bone tumor cells. Clin. Cancer Res. 2002 Dec;8(12):3893-903. I.F. (2016/2017): 9.619

71. M Serra, K Scotlandi, G Reverter-Branchat, S Ferrari, MC Manara, S Benini, M Incaprera, F Bertoni, M Mercuri, A Briccoli, G Bacci, P Picci.

    Value of P-glycoprotein and clinico-pathological factors as basis for new treatment strategies in high-grade osteosarcoma of the extremities. J. Clin. Oncol. 2003 Feb 1;21(3):536-42. I.F. (2016/2017): 24.008

72. M Sanchez-Carbayo, TJ Belbin, K Scotlandi, M Prystowsky, N Baldini, G Childs, C Cordon-Cardo.

    Expression profiling of osteosarcoma cells transfected with MDR1 and NEO genes: regulation of cell adhesion, apoptosis, and tumor suppression-related genes. Lab Invest. 2003 Apr;83(4):507-17. I.F. (2016/2017): 4.857

73. N Coltella, MC Manara, V Cerisano, L Trusolino, MF Di Renzo, K Scotlandi, R Ferracini.

    Role of the MET/HGF receptor in proliferation and invasive behavior of osteosarcoma.

    Faseb J. 2003 Jun;17(9):1162-4. Epub 2003 Apr 22. I.F. (2016/2017): 5.498

74. K Scotlandi , MC Manara, R Strammiello, L Landuzzi, S Benini, S Perdichizzi, M Serra, A Astolfi, G Nicoletti, PL Lollini, F Bertoni, P Nanni, P Picci.

    C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions. J Clin Oncol. 2003 May 15;21(10):1952-60. I.F. (2016/2017): 24.008

75. CM Hattinger, G Reverter-Branchat, D Remondini, GC Castellani, S Benini, M Pasello, MC Manara, K Scotlandi, P Picci, M Serra.

    Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques. Eur. J. Cell Biol. 2003 Sep;82(9):483-93. I.F. (2016/2017): 3.712

76. R Strammiello, S Benini, MC Manara, S Perdichizzi, M Serra, E Spisni, P Picci, K Scotlandi.

    Impact of IGF/IGF-IR circuit on the angiogenetic properties of Ewing’s sarcoma cells. Hormone and Metabolic Res. 2003 Nov-Dec;35(11-12):675-84. I.F. (2016/2017): 2.268

77. P Picci, K Scotlandi, M Serra.

    The role of basic research in clinical treatment of Ewing's sarcoma and osteosarcoma. Chir Organi Mov. 2003 Apr-Jun;88(2):201-9. Review.

78. MC Manara, M Serra, S Benini, P Picci, K Scotlandi.

    Effectiveness of type I interferons in the treatment of multidrug resistant osteosarcoma cells.

    Int. J. Oncol. 2004 Feb;24(2):365-72. I.F. (2016/2017): 3.079

79. S Benini, MC Manara, V Cerisano, S Pedichizzi, R Strammiello, M Serra, P Picci,K Scotlandi.

    Contribution of MEK/MAPK and PI3-K signaling pathway to the malignant behaviour of Ewing’s sarcoma cells: therapeutic prospects. Int. J. Cancer. 2004 Jan 20;108(3):358-66. I.F. (2016/2017): 6.513

80. M Serra, G Reverter-Branchat, D Maurici, S Benini, JN Shen, T Chano, CM Hattinger, MC Manara, M Pasello, K Scotlandi, P Picci.

    Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells. Ann Oncol. 2004 Jan;15(1):151-60. I.F. (2016/2017): 11.855 

81. T Chano, K Mori, K Scotlandi, S Benini, C Lapucci, MC Manara, M Serra, P Picci, H Okabe, N Baldini.

    Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells. Oncol Rep. 2004 Jun;11(6):1257-63. I.F. (2016/2017): 2.662

82. CM Hattinger, M Tarkkanen, S Benini, M Pasello, G Stoico, P Bacchini, S Knuutila, K Scotlandi, P Picci, M Serra.  Genetic analysis of fibrosarcoma of bone, a rare tumour entity closely related to osteosarcoma and malignant fibrous histiocytoma of bone. Eur J Cell Biol. 2004 Sep;83(9):483-91. I.F. (2016/2017): 3.712
83.  E Cagliero, R Ferracini, E Morello, K Scotlandi, MC Manara, P Buracco, A Comandone, R Baroetto Parisi, N Baldini. Reversal of multidrug-resistance using Valspodar (PSC 833) and doxorubicin in osteosarcoma. Oncol Rep. 2004 Nov;12(5):1023-31. I.F. (2016/2017): 2.662